» Articles » PMID: 34115352

Bead-Based Assays for Validating Proteomic Profiles in Body Fluids

Overview
Specialty Molecular Biology
Date 2021 Jun 11
PMID 34115352
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Protein biomarkers in biological fluids represent an important resource for improving the clinical management of diseases. Current proteomics technologies are capable of performing high-throughput and multiplex profiling in different types of fluids, often leading to the shortlisting of tens of candidate biomarkers per study. However, before reaching any clinical setting, these discoveries require thorough validation and an assay that would be suitable for routine analyses. In the path from biomarker discovery to validation, the performance of the assay implemented for the intended protein quantification is extremely critical toward achieving reliable and reproducible results. Development of robust sandwich immunoassays for individual candidates is challenging and labor and resource intensive, and multiplies when evaluating a panel of interesting candidates at the same time. Here we describe a versatile pipeline that facilitates the systematic and parallel development of multiple sandwich immunoassays using a bead-based technology.

Citing Articles

Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis.

Fernandez Turizo M, Patell R, Zwicker J Bleeding Thromb Vasc Biol. 2024; 3(Suppl 1).

PMID: 38828226 PMC: 11143428. DOI: 10.4081/btvb.2024.120.


Proteomics in thrombosis research.

Edfors F, Iglesias M, Butler L, Odeberg J Res Pract Thromb Haemost. 2022; 6(3):e12706.

PMID: 35494505 PMC: 9039028. DOI: 10.1002/rth2.12706.

References
1.
Williams S, Kivimaki M, Langenberg C, Hingorani A, Casas J, Bouchard C . Plasma protein patterns as comprehensive indicators of health. Nat Med. 2019; 25(12):1851-1857. PMC: 6922049. DOI: 10.1038/s41591-019-0665-2. View

2.
Geyer P, Holdt L, Teupser D, Mann M . Revisiting biomarker discovery by plasma proteomics. Mol Syst Biol. 2017; 13(9):942. PMC: 5615924. DOI: 10.15252/msb.20156297. View

3.
Wright I, Van Eyk J . A Roadmap to Successful Clinical Proteomics. Clin Chem. 2016; 63(1):245-247. PMC: 10952121. DOI: 10.1373/clinchem.2016.254664. View

4.
Bachmann J, Burte F, Pramana S, Conte I, Brown B, Orimadegun A . Affinity proteomics reveals elevated muscle proteins in plasma of children with cerebral malaria. PLoS Pathog. 2014; 10(4):e1004038. PMC: 3990714. DOI: 10.1371/journal.ppat.1004038. View

5.
Haggmark A, Bystrom S, Ayoglu B, Qundos U, Uhlen M, Khademi M . Antibody-based profiling of cerebrospinal fluid within multiple sclerosis. Proteomics. 2013; 13(15):2256-67. DOI: 10.1002/pmic.201200580. View